Effect of Nebivolol on Remodeling of the Heart and Vessels and the State of Hemodynamics in Patients with Hypertension

Kardiologiya

Volumn 42, Issue 10, 2002, Pages 27-30

  Gromnatsky, N I ^a   Dyusmikeeva, N B ^a  

^a NONE

Author keywords

Hypertension; Nebivolol; Remodeling; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENZOPYRAN DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETHANOLAMINE DERIVATIVE; NEBIVOLOL; VASODILATOR AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; DIASTOLE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; DATA INTERPRETATION, STATISTICAL; DIASTOLE; ETHANOLAMINES; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0346673810     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ganau A., Devereux R.B., Roman M.J. et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1559-1560.
2. Koren M.J., Devereux R.B., Casale P.N. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
3. Schiffrin E.L., Deng L.Y., Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993;16:177-186.
4. Taddei S., Salvetti A. Pathogenetic factors in hypertension. Endothelial factors. Clin Exp Hypertens 1996;8:323-335.
5. Taddei S., Virdis A., Ghiadoni L., Salvetti A. The role of endothelium in human hypertension. Curr Opin Nephron Hypertens 1998;7:203-209.
6. Stock Th.K., Muller R.M., Piske G. et al. Noninvasivemeasurement of left ventricular filling pressures by means of transmitral pulsed Doppler ultrasound. Am J Cardiol 1989;64:655-660.
7. Cockcroft J.R., Chowienezyk P.J., Brett S.E. et al. Nebivolol vasodilates human foream vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 1995;274:1067-1071.
8. Cheymol G., Woestenborghs R., Snoeck E. et al. Pharmacokinetic study and cardiovascular monitoring of nebivolol in mormal and obese subjects. Eur J Clin Pharmacol 1997;51:493-498.